AI brief of an SEC Form 8-K · Hims & Hers Health (HIMS)

Hims & Hers appoints Andrew Huberman to board, signs $3.5 million advisory deal

Neutral Impact 3 of 5 leadership

Hims & Hers expanded its board from nine to ten directors and appointed Dr. Andrew Huberman, 51, effective immediately, as a director who is not independent under NYSE standards. The same week, the company's subsidiary agreed to pay Dr. Huberman a $3.5 million annual advisory fee and a separate company agreement pays his media company, Scicomm Media, $5 million a year, a related-party arrangement that shareholders may weigh against the board seat.

Key points

  • Dr. Andrew Huberman, 51, appointed to the board on November 4, 2026, filling a newly created seat; not on any committee.
  • Advisory Agreement dated November 5, 2026: $3,500,000 annual cash fee for two years, plus up to $1,000,000 per year for short-form videos.
  • Marketing Agreement with Scicomm Media LLC, co-owned by Dr. Huberman: $5,000,000 annual fee for up to three years; his interest is about $2,100,000 annually.
  • Director cash retainer of $50,000 and equity award valued at $250,000, prorated through the 2027 annual meeting.

The filing

CompanyHims & Hers Health (HIMS)
Form8-K, current report
Filed with the SECNov 9, 2026, 4:13 PM ET
Accession number0001773751-26-000245

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 4:16 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.